Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY, PARTNERS??? CAPITAL AND REDEEMABLE NONCONTROLLING INTEREST

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY, PARTNERS’ CAPITAL AND REDEEMABLE NONCONTROLLING INTEREST - USD ($)
$ in Thousands
Total
Common Stock
Partnership Units
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interest
Total Stockholders’ Equity              
Equity-based compensation $ 523     $ 523      
Net income (loss) 1,790         $ 1,472 $ 318
Beginning balance (in shares) at Dec. 31, 2020 [1]     114,167,842        
Beginning balance at Dec. 31, 2020 138,884   $ 108,197 [1] 727 $ 5,839 14,138 9,983
Partnership Equity              
Issuance of units (in shares) [1]     25,746,282        
Issuance of units 82,669   $ 82,669 [1]        
Equity-based compensation 523     523      
Cumulative translation adjustment (3,842)       (3,444)   (398)
Net income 1,790         1,472 318
Ending balance (in shares) at Mar. 31, 2021 [1]     139,914,124        
Ending balance at Mar. 31, 2021 220,024   $ 190,866 [1] 1,250 2,395 15,610 9,903
Beginning balance at Dec. 31, 2020 0            
Redeemable Noncontrolling Interest              
Noncontrolling interest from purchase of Culture Kings 142,717            
Cumulative translation adjustment (1,575)            
Ending balance at Mar. 31, 2021 141,142            
Total Stockholders’ Equity              
Cumulative translation adjustment (11,099)            
Net income (loss) 3,979            
Beginning balance (in shares) at Dec. 31, 2020 [1]     114,167,842        
Beginning balance at Dec. 31, 2020 138,884   $ 108,197 [1] 727 5,839 14,138 9,983
Partnership Equity              
Net income 3,979            
Ending balance (in shares) at Jun. 30, 2021 [1]     139,914,124        
Ending balance at Jun. 30, 2021 219,471   $ 190,866 [1] 1,859 (1,314) 18,041 10,019
Beginning balance at Dec. 31, 2020 0            
Ending balance at Jun. 30, 2021 138,812            
Total Stockholders’ Equity              
Equity-based compensation 609     609      
Cumulative translation adjustment (5,681)            
Net income (loss) 2,189            
Beginning balance (in shares) at Mar. 31, 2021 [1]     139,914,124        
Beginning balance at Mar. 31, 2021 220,024   $ 190,866 [1] 1,250 2,395 15,610 9,903
Partnership Equity              
Equity-based compensation 609     609      
Cumulative translation adjustment (3,846)       (3,709)   (137)
Net income (loss) 2,684         2,431 253
Net income 2,189            
Ending balance (in shares) at Jun. 30, 2021 [1]     139,914,124        
Ending balance at Jun. 30, 2021 219,471   $ 190,866 [1] 1,859 (1,314) 18,041 $ 10,019
Beginning balance at Mar. 31, 2021 141,142            
Redeemable Noncontrolling Interest              
Cumulative translation adjustment (1,835)            
Net income (loss) (495)            
Ending balance at Jun. 30, 2021 $ 138,812            
Beginning balance (in shares) at Dec. 31, 2021 128,647,836 128,647,836          
Beginning balance at Dec. 31, 2021 $ 451,026 $ 129   453,807 (11,080) 8,170  
Total Stockholders’ Equity              
Equity-based compensation 1,368     1,368      
Cumulative translation adjustment 14,405       14,405    
Net income (loss) 1,525         1,525  
Ending balance (in shares) at Mar. 31, 2022   128,647,836          
Ending balance at Mar. 31, 2022 468,324 $ 129   455,175 3,325 9,695  
Partnership Equity              
Equity-based compensation 1,368     1,368      
Net income $ 1,525         1,525  
Beginning balance (in shares) at Dec. 31, 2021 128,647,836 128,647,836          
Beginning balance at Dec. 31, 2021 $ 451,026 $ 129   453,807 (11,080) 8,170  
Total Stockholders’ Equity              
Cumulative translation adjustment (24,626)            
Net income (loss) $ (2,687)            
Ending balance (in shares) at Jun. 30, 2022 128,669,181 128,669,181          
Ending balance at Jun. 30, 2022 $ 426,543 $ 129   456,637 (35,706) 5,483  
Partnership Equity              
Net income (2,687)            
Beginning balance (in shares) at Mar. 31, 2022   128,647,836          
Beginning balance at Mar. 31, 2022 468,324 $ 129   455,175 3,325 9,695  
Total Stockholders’ Equity              
Equity-based compensation $ 1,494     1,494      
Issuance of common stock upon settlement of equity awards, net of shares withheld (in shares) 21,345            
Issuance of common stock upon settlement of equity awards, net of shares withheld $ (32)            
Cumulative translation adjustment (39,031)       (39,031)    
Net income (loss) $ (4,212)         (4,212)  
Ending balance (in shares) at Jun. 30, 2022 128,669,181 128,669,181          
Ending balance at Jun. 30, 2022 $ 426,543 $ 129   456,637 $ (35,706) 5,483  
Partnership Equity              
Equity-based compensation 1,494     $ 1,494      
Net income $ (4,212)         $ (4,212)  
[1] Excelerate, L.P. was the predecessor entity to a.k.a. Brands Holding Corp. Refer to Note 1 for additional information.